Search research articles
Contact Us
Filters
Showing results (441-450 of 523) with videos related to
Page
of 53
Sort By:
Journal of Alzheimer'S Disease : JAD
|
November 14, 2022
Wisconsin Healthcare Utilization Cost Among American Indians/Alaska Natives with and without Alzheimer's Disease and Related Dementias
Adrienne L Johnson, Elaina Seep, Derek L Norton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 1999
Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer
G D'Andrea, D Fennelly, L Norton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2004
The NHL-15 protocol for aggressive non-Hodgkin's lymphomas: a sequential dose-dense, dose-intense regimen of doxorubicin, vincristine and high-dose cyclophosphamide
C S Portlock, J Qin, P Schaindlin, et al.
Blood Advances
|
June 4, 2020
Young adult outcomes of childhood prophylaxis for severe hemophilia A: results of the Joint Outcome Continuation Study
Beth Boulden Warren, Dianne Thornhill, Jill Stein, et al.
The Science of the Total Environment
|
January 27, 2020
Exoskeleton dissolution with mechanoreceptor damage in larval Dungeness crab related to severity of present-day ocean acidification vertical gradients
Nina Bednaršek, Richard A Feely, Marcus W Beck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 1998
Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer
C Aghajanian, D Fennelly, F Shapiro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1996
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer
J Baselga, D Tripathy, J Mendelsohn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2003
Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140
H L Parnes, C Cirrincione, J Aisner, et al.
Seminars in Oncology
|
September 11, 1999
Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer
J Baselga, D Tripathy, J Mendelsohn, et al.
Science (New York, N.Y.)
|
February 8, 2024
In Science Journals
Wei Wong, Ankit Walia, Jelena Stajic, et al.
Page
of 53
Search research articles
Search
Showing results (441-450 of 523) with videos related to
Sort By:
Page
of 53
Journal of Alzheimer'S Disease : JAD
|
November 14, 2022
Wisconsin Healthcare Utilization Cost Among American Indians/Alaska Natives with and without Alzheimer's Disease and Related Dementias
Adrienne L Johnson, Elaina Seep, Derek L Norton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 1999
Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer
G D'Andrea, D Fennelly, L Norton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2004
The NHL-15 protocol for aggressive non-Hodgkin's lymphomas: a sequential dose-dense, dose-intense regimen of doxorubicin, vincristine and high-dose cyclophosphamide
C S Portlock, J Qin, P Schaindlin, et al.
Blood Advances
|
June 4, 2020
Young adult outcomes of childhood prophylaxis for severe hemophilia A: results of the Joint Outcome Continuation Study
Beth Boulden Warren, Dianne Thornhill, Jill Stein, et al.
The Science of the Total Environment
|
January 27, 2020
Exoskeleton dissolution with mechanoreceptor damage in larval Dungeness crab related to severity of present-day ocean acidification vertical gradients
Nina Bednaršek, Richard A Feely, Marcus W Beck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 1998
Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer
C Aghajanian, D Fennelly, F Shapiro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1996
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer
J Baselga, D Tripathy, J Mendelsohn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2003
Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140
H L Parnes, C Cirrincione, J Aisner, et al.
Seminars in Oncology
|
September 11, 1999
Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer
J Baselga, D Tripathy, J Mendelsohn, et al.
Science (New York, N.Y.)
|
February 8, 2024
In Science Journals
Wei Wong, Ankit Walia, Jelena Stajic, et al.
Page
of 53